Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis

BACKGROUND: Fibulin-3 (FBLN3) was recently presented as a promising novel biomarker for malignant pleural mesothelioma (MPM), warranting independent validation studies. METHODS: ELISA was used to measure cellular and secreted FBLN3 in cell lines, in plasma of xenograft tumour-bearing mice, in plasma...

詳細記述

保存先:
書誌詳細
出版年:Br J Cancer
主要な著者: Kirschner, Michaela B, Pulford, Emily, Hoda, Mir Alireza, Rozsas, Anita, Griggs, Kim, Cheng, Yuen Yee, Edelman, J James B, Kao, Steven C, Hyland, Rebecca, Dong, Yawen, László, Viktoria, Klikovits, Thomas, Vallely, Michael P, Grusch, Michael, Hegedus, Balazs, Dome, Balazs, Klepetko, Walter, van Zandwijk, Nico, Klebe, Sonja, Reid, Glen
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group 2015
主題:
Molecular Diagnostics
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4578085/
https://ncbi.nlm.nih.gov/pubmed/26263483
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.286
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料